Caregivers
147 articles
At the Table: Taking Care During the COVID-19 Pandemic
Pancreatic cancer survivors discuss the different ways they are being careful to avoid catching COVID-19 during the pandemic.
Symptom Management for Pancreatic Cancer Patients
Manage pancreatic cancer treatment symptoms and side effects with effective symptom management techniques from oncologist Dr. Kim A. Reiss.
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Medical Diet Study for Pancreatic Cancer Patients
Researchers are looking at the role of one particular nutrient in a diet study for pancreatic cancer patients.
Combining Two Drugs with Different Approaches to Enhance Treatment
A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.
Testing a New Drug to Attack Pancreatic Tumor Blood Vessels
A clinical trial is testing a new drug combination that damages the tumor blood vessels and allows chemotherapy drugs to enter the tumor.
Electric Fields to Enhance Pancreatic Cancer Chemotherapy
A clinical trial uses electric fields to help slow the growth of tumor cells, In a clinical trial for pancreatic cancer patients.
Testing a New Drug on Advanced Pancreatic Neuroendocrine Tumors
In a clinical trial, the new drug sapanisertib is being tested for its effectiveness against pancreatic neuroendocrine tumors (PNETs).
Testing a Breast Cancer Drug for Other Advanced Solid Tumors
In a clinical trial, a new class of breast cancer drug called a kinase inhibitor is being tested to treat pancreatic cancer.
Trying a New Type of Treatment to Stop Advanced Pancreatic Cancer
Researchers test the chemotherapy combination of AM0010 and FOLFOX as a second-line therapy for people with metastatic pancreatic cancer.
Testing the Safety of a New Chemotherapy and Radiation Combination
A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.
Adding a New Drug to Standard Treatment for Metastatic Pancreatic Cancer
A clinical trial tests the effectiveness of napabucasin, a drug that affects the signaling pathways of cancer stem cells.